Hypoglycaemia : Although less common with Ozempic monotherapy, low blood sugar episodes can occur, especially when combined with other diabetes medications like insulin or sulfonylureas
We take a holistic wellness approach to maximize the benefits of Semaglutide
Medical evaluation Your provider reviews your health history, medications, weight loss goals, and eligibility criteria
Unlike semaglutide (GLP1 agonist) or tirzepatide (GLP1/GIP dual agonist), retatrutide uniquely targets and activates three hormone receptors (GLP1, GIP, and glucagon) granting it a powerful tripleagonist mechanism. In a 48-week clinical trial, participants lost up to 24.2% of their body weight, with improvements also seen in cholesterol, triglycerides, and other metabolic markers
At our practice, we prioritize patient safety and efficacy